Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists probe immune System's role in rare brain disorders

NCT ID NCT04925349

First seen Sep 30, 2025 · Last updated Jun 19, 2026 · Updated 35 times

Summary

This study looks at how immune cells called macrophages behave in people with rare brain diseases like adrenoleukodystrophy and metachromatic leukodystrophy. Researchers will collect blood samples from 100 participants to analyze immune cell activity and metabolism. The goal is to understand if these immune responses drive disease progression, which could help develop future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADRENOLEUKODYSTROPHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AP-HP Hôpital Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, 94275, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • AP-HP Hôpital La Pitié Salpêtrière

    RECRUITING

    Paris, 75013, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal how the immune system affects these rare brain diseases, pointing toward future treatment targets.

What could go wrong

This is an observational study with no treatment being tested. It is small and early-stage, so findings may not lead directly to therapies.

Conditions

The condition(s) this trial relates to.

adrenoleukodystrophy adrenomyeloneuropathy central nervous system disorder leukoencephalopathy, diffuse hereditary, with spheroids 1 metachromatic leukodystrophy nervous system disorder Neuroinflammatory Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.